Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: a real-world observational study in the United States von Hultcrantz, Malin, Kleinman, David, Vij, Ravi, Escalante, Fernando, Delforge, Michel, Kotowsky, Nirali, Bitetti, Jacopo, Boytsov, Natalie, Camadoo-O'Byrne, Leena, Happ, Lindsey Powers, Germain, Guillaume, Urosevic, Ana, Mahendran, Malena, Duh, Mei Sheng, Laliberte, Francois, Cavo, Michele, Lee, Hans C

Volltext

PB2114: BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: A REAL‐WORLD OBSERVATIONAL STUDY UPDATE von Hultcrantz, Malin, Kleinman, David, Vij, Ravi, Escalante, Fernando, Delforge, Michel, Kotowsky, Nirali, Bitetti, Jacopo, Boytsov, Natalie, Camadoo‐O’byrne, Leena, Happ, Lindsey Powers, Rohman, Mujib, Germain, Guillaume, Duh, Mei Sheng, Laliberté, François, Mahendran, Malena, Urosevic, Ana, Lee, Hans C.

Volltext

Belantamab mafodotin (belamaf) for relapsed/refractory multiple myeloma (RRMM): A real-world observational study update von Hultcrantz, Malin, Kleinman, David, Vij, Ravi, Escalante, Fernando, Delforge, Michel, Kotowsky, Nirali, Bitetti, Jacopo, Boytsov, Natalie, Camadoo-O'Byrne, Leena, Powers Happ, Lindsey, Rohman, Mujib, Germain, Guillaume, Duh, Mei Sheng, Laliberté, François, Mahendran, Malena, Urosevic, Ana, Lee, Hans C.

Volltext

Belantamab Mafodotin (Belamaf) for Relapsed/Refractory Multiple Myeloma (RRMM): A Real-World Observational Study von Hultcrantz, Malin, Kleinman, David, Vij, Ravi, Escalante, Fernando, Kotowsky, Nirali, Bitetti, Jacopo, Mackay, Christine, Boytsov, Natalie, Camadoo-O'Byrne, Leena, Germain, Guillaume, Duh, Mei Sheng, Laliberté, François, Mahendran, Malena, Urosevic, Ana, Lee, Hans C.

Volltext

POSTER: MM-508 Belantamab Mafodotin for Relapsed or Refractory Multiple Myeloma: A Real-World Observational Study Update von Hultcrantz, Malin, Kleinman, David, Vij, Ravi, Escalante, Fernando, Delforge, Michel, Kotowsky, Nirali, Bitetti, Jacopo, Boytsov, Natalie, Camadoo-O'Byrne, Leena, Happ, Lindsey Powers, Rohman, Mujib, Germain, Guillaume, Duh, Mei Sheng, Laliberté, François, Mahendran, Malena, Urosevic, Ana, Lee, Hans

Volltext

MM-508 Belantamab Mafodotin for Relapsed or Refractory Multiple Myeloma: A Real-World Observational Study Update von Hultcrantz, Malin, Kleinman, David, Vij, Ravi, Escalante, Fernando, Delforge, Michel, Kotowsky, Nirali, Bitetti, Jacopo, Boytsov, Natalie, Camadoo-O'Byrne, Leena, Happ, Lindsey Powers, Rohman, Mujib, Germain, Guillaume, Duh, Mei Sheng, Laliberté, François, Mahendran, Malena, Urosevic, Ana, Lee, Hans

Volltext

P-238 A real-world observational study of belantamab mafodotin (belamaf) as a treatment for relapsed/ refractory multiple myeloma (RRMM) von Cavo, Michele, Delforge, Michel, Dimopoulos, Meletios, Escalante, Fernando, Hultcrantz, Malin, Kleinman, David, Lee, Hans, Vij, Ravi, Kotowsky, Nirali, Camadoo-O'Byrne, Leena, Bitetti, Jacopo, D'Estrube, Tim, Fry, Mark, Vossen, Carla

Volltext

P-272 Belantamab mafodotin for relapsed/refractory multiple myeloma: a real-world observational study update von Hultcrantz, Malin, Kleinman, David, Vij, Ravi, Escalante, Fernando, Delforge, Michel, Kotowsky, Nirali, Bitetti, Jacopo, Boytsov, Natalie, Camadoo-O'Byrne, Leena, Happ, Lindsey Powers, Rohman, Mujib, Germain, Guillaume, Duh, Mei Sheng, Laliberte, Francois, Mahendran, Malena, Urosevic, Ana, Lee, Hans

Volltext

P-421 Characteristics of Patients and Management of Ocular Adverse Events After Treatment With Belantamab Mafodotin (Belamaf) in Relapsed/Refractory Multiple Myeloma (RRMM): A Real... von Cavo, Michele, Delforge, Michel, Dimopoulos, Meletios, Escalante-Barrigon, Fernando, Hultcrantz, Malin, Kleinman, David, Lee, Hans, Vij, Ravi, Greil, Richard, Melchardt, Thomas, Antonioli, Elisabetta, Schjesvold, Fredrik, Lysén, Anna, Kotowsky, Nirali, Camadoo-O'Byrne, Leena, Bitetti, Jacopo, Mouro, Jorge, D'Estrube, Tim, Fry, Mark, Byrne, Julie, Vossen, Carla

Volltext